Q32 Bio Inc. (QTTB)

Q32 Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	116.16	31.26	33.99	110.34	218.71	55.05
Short-Term Investments	19.8	0	141.04	47.49	0	208.61
Cash & Cash Equivalents	135.96	31.26	175.03	157.83	218.71	263.66
Cash Growth	-9.38%	-82.14%	10.90%	-27.84%	-17.05%	21.78%
Other Current Assets	2.08	-2.55	5.99	34.08	0.86	2.92
Total Current Assets	138.04	28.72	181.02	191.91	219.56	266.58
Property, Plant & Equipment	7.82	8.08	21.64	17.86	42.9	42.72
Long-Term Investments	4.72	0	25.81	0	0	0
Other Long-Term Assets	1.75	10.26	0	1.95	1.27	1.27
Total Long-Term Assets	14.29	18.34	47.46	19.81	44.17	43.99
Total Assets	152.33	47.06	228.47	211.72	263.74	310.57
Accounts Payable	4.96	3.47	1.14	2.37	4.72	2.61
Deferred Revenue	0	0	1.16	4.36	37.78	30.95
Current Debt	3.09	0.88	1.56	0.25	2.5	0
Other Current Liabilities	24.91	9.76	18.72	10.25	-22.34	-21.19
Total Current Liabilities	32.95	14.11	22.58	17.23	22.66	12.37
Long-Term Debt	15.5	49.42	27.92	23.69	12.94	0
Other Long-Term Liabilities	55.11	55	0	1.16	32.14	39.69
Total Long-Term Liabilities	70.61	104.42	27.92	24.84	45.08	39.69
Total Liabilities	103.57	118.53	50.49	42.07	67.74	52.06
Total Debt	18.59	50.3	29.48	23.93	15.44	0
Debt Growth	-36.13%	70.65%	23.16%	54.99%	-	-
Retained Earnings	-186.05	-187.08	-429.14	-424.13	-328.37	-199.67
Comprehensive Income	-0.01	0	-0.4	-0.01	0	0.18
Shareholders' Equity	48.77	-182.92	177.98	169.65	196	258.51
Net Cash / Debt	117.37	-19.04	145.55	133.89	203.26	263.66
Net Cash / Debt Growth	-2.94%	-	8.71%	-34.13%	-22.91%	21.78%
Net Cash Per Share	50.28	-5.93	45.64	43.59	79.69	112.68
Working Capital	105.09	14.61	158.44	174.68	196.91	254.2
Book Value Per Share	49.00	-56.93	55.81	55.24	76.84	110.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).